Risk assessment and management of hepatitis B reactivation from direct-acting antivirals for hepatitis C
Although hepatitis B virus (HBV) reactivation has been reported in hepatitis C patients who received interferon therapy, rare cases of HBV reactivation occur in the context of direct-acting antiviral (DAA) agent therapy for treatment of hepatitis C virus (HCV) infection. Recent studies observed that...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2019-06-01
|
| Series: | Liver Research |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2542568418300382 |